CompletedNo phase
Remote Support for Cochlear Implant Recipients: Evaluation of the HearCare MED-EL App
Key facts
- Who runs it
- MED-EL Elektromedizinische Geräte GmbH
- Where
- Germany3 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 120 people enrolled
- Started
- 20 Aug 2024
- Ended
- 26 Nov 2025
- Type of study
- Interventional
- Treatments tested
- HearCare MED-EL App
- Record updated
- 1 December 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Age > 18 years
- Implanted with at least one MED-EL Cochlea Implant (CI) for at least 3 months
- Fitted with at least one audio processor compatible with the HearCare MED-EL App (i.e. SONNET 2, SONNET 2 EAS, RONDO 3 or newer)
- Signed and dated Informed Consent Form (ICF) before the start of any study-specific procedure
Who cannot take part
- Implanted with an Auditory Brainstem Implant (ABI) or Split electrode array
- Anything that, in the opinion of the Investigator, would place the subject at increased risk or preclude the subject's full compliance with or completion of the study (e.g. psychological disorders, neurologic or motoric comorbidity that could restrict subjects from using the app)
- Lack of compliance with any inclusion criteria
- Implanted with C40X and C40C
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This clinical investigation intends to assess safety and performance of the HearCare MED-EL App, a remote care option for recipients of MED-EL cochlear implants
The group in the trial
- HearCare MED-EL AppOther group
Subjects perform system check and install audio processor configuration via the HearCare MED-EL App
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 1 December 2025